MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers
- PMID: 16969504
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers
Abstract
MicroRNAs (miRNAs) are endogenously expressed RNAs 18-24 nucleotides in length that regulate gene expression through translational repression by binding to a target mRNA. It is thought that the expression level of miRNAs, which act like antioncogenes, is frequently reduced in cancers because of chromosome deletion and epigenetic changes. Since the processing of miRNAs has been characterized to be enzymatic in nature, the expression levels of miRNAs are closely associated with the activity and levels of such enzymes. Here, we found that miRNA 143 and 145 expression levels were extremely reduced in colon cancer cells and commonly in the other kinds of cancer cells tested. The transfection of each precursor miRNA into the cells demonstrated a significant growth inhibition in human colon cancer DLD-1 and SW480 cells, and ERK5 was determined to be the target gene of miRNA 143. Since the presence of genomic loci of the miRNAs was confirmed by PCR in the cell lines and the precursor miRNAs exhibited a growth inhibitory effect in DLD-1 and SW480 cells, the early processes such as transcription and enzymatic modification from primary miRNAs to precursor miRNAs seemed to be commonly disturbed. These findings indicate that the miRNAs 143 and 145 could become good tumor markers and provide an important clue in the study of the mechanism of oncogenesis involving miRNAs.
Similar articles
-
5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.Oncol Rep. 2010 Jan;23(1):121-8. Oncol Rep. 2010. PMID: 19956872
-
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24. doi: 10.1158/1078-0432.CCR-05-1853. Clin Cancer Res. 2006. PMID: 16609010
-
MicroRNAs and cancer.Br J Surg. 2007 Jan;94(1):23-30. doi: 10.1002/bjs.5673. Br J Surg. 2007. PMID: 17205498 Review.
-
Target identification of microRNAs expressed highly in human embryonic stem cells.J Cell Biochem. 2009 Apr 15;106(6):1020-30. doi: 10.1002/jcb.22084. J Cell Biochem. 2009. PMID: 19229866
-
MicroRNAs and cancer.APMIS. 2007 Oct;115(10):1090-106. doi: 10.1111/j.1600-0463.2007.apm_775.xml.x. APMIS. 2007. PMID: 18042145 Review.
Cited by
-
KRAS Promoter Methylation Status and miR-18a-3p and miR-143 Expression in Patients With Wild-type KRAS Gene in Colorectal Cancer.Cancer Diagn Progn. 2022 Sep 3;2(5):576-584. doi: 10.21873/cdp.10145. eCollection 2022 Sep-Oct. Cancer Diagn Progn. 2022. PMID: 36060016 Free PMC article.
-
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus.Exp Ther Med. 2013 Jan;5(1):338-342. doi: 10.3892/etm.2012.787. Epub 2012 Nov 1. Exp Ther Med. 2013. PMID: 23251295 Free PMC article.
-
How microRNAs influence both hereditary and inflammatory-mediated colon cancers.Cancer Genet. 2013 Sep-Oct;206(9-10):309-16. doi: 10.1016/j.cancergen.2013.06.005. Epub 2013 Sep 14. Cancer Genet. 2013. PMID: 24042167 Free PMC article. Review.
-
EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.Mol Cancer Res. 2011 Jul;9(7):960-75. doi: 10.1158/1541-7786.MCR-10-0531. Epub 2011 Jun 8. Mol Cancer Res. 2011. PMID: 21653642 Free PMC article.
-
Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets.Oncotarget. 2017 Mar 7;8(10):17328-17346. doi: 10.18632/oncotarget.14461. Oncotarget. 2017. PMID: 28061475 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous